Affected Systems

CGM CLININET healthcare software: all versions before 2026.MS3 affected by most vulnerabilities. CVE-2025-30049 fixed in 2026.MS1 and 2026.MS3. Multiple vulnerabilities (CVE-2025-30045, CVE-2025-30046, CVE-2025-30052, CVE-2025-30053, CVE-2025-30054, CVE-2025-58403) confirmed through 2026.MS3 but may affect later versions.

Exploitation Status

No active exploitation reported. Vulnerabilities disclosed via coordinated disclosure through CERT Polska. Multiple attack vectors require adjacent network access or authenticated high-privilege access. No public PoC mentioned.

Business Impact

Healthcare organizations using CGM CLININET face severe risk: unauthenticated attackers on adjacent networks can access patient documents (CVE-2025-30043), achieve remote code execution as root via deserialization (CVE-2025-30047), HL7 injection (CVE-2025-30046), or code injection (CVE-2025-30050). Weak MD5 password hashing (CVE-2025-30049) and credential exposure in config files (CVE-2025-30051) enable privilege escalation. Authentication bypass via IP spoofing (CVE-2025-30052) and missing authentication (CVE-2025-30053) compound the risk. HIPAA and patient data confidentiality at risk. CVSS scores not published.

Urgency

🔴 Immediate

Recommended Actions

  • Immediately upgrade CGM CLININET to version 2026.MS3 or later to remediate 9 of 11 CVEs; verify with vendor if CVE-2025-30045, CVE-2025-30046, CVE-2025-30052, CVE-2025-30053, CVE-2025-30054, and CVE-2025-58403 are fully patched
  • Isolate CGM CLININET servers from adjacent networks using network segmentation and firewall rules; restrict HL7 interface access to trusted medical device IPs only
  • Audit local user accounts with access to CGM CLININET servers; review SysIO.pl file permissions and rotate database and RabbitMQ credentials immediately
  • Monitor CGM CLININET logs for unauthorized access to /DocManagment endpoint, unusual HL7 traffic, and unexpected Java deserialization or Perl module imports
  • Force password resets for all CGM CLININET users due to weak MD5 hashing (CVE-2025-30049); implement MFA if supported by version 2026.MS3 or later

---

# Geopolitical Context

Geopolitical Context

The disclosure by CERT Polska of multiple critical vulnerabilities in CGM CLININET—a healthcare information system—reflects Poland's active role in European cybersecurity coordination and responsible vulnerability disclosure. CGM, a major European healthcare IT vendor with significant market presence across the EU, represents critical infrastructure in the health sector. The vulnerabilities, including authentication bypass, code injection, and insecure deserialization flaws enabling root-level remote code execution, pose substantial risk to healthcare delivery systems. This disclosure appears consistent with Poland's broader effort to strengthen cyber resilience within NATO and EU frameworks, particularly in sectors designated as critical under the NIS2 Directive. The timing and coordination suggest mature vulnerability handling processes aligned with Western cybersecurity norms.

State Actor Alignment

No state actor involvement is indicated in this event. The disclosure follows a standard coordinated vulnerability disclosure (CVD) process, with CERT Polska receiving an external vulnerability report and coordinating public disclosure with the vendor. This represents routine national CERT activity consistent with Poland's obligations under EU cybersecurity frameworks and its participation in the CSIRT network. The healthcare sector's designation as critical infrastructure under both Polish national law and EU directives (NIS2) likely informed the handling and prioritization of this disclosure. No sanctions, attribution, or state-sponsored threat activity is associated with this technical advisory.

Business Impacty pro region

The vulnerabilities affect CGM CLININET deployments across Europe, where CGM maintains substantial market share in healthcare IT systems. Healthcare providers in Germany, Poland, and other EU member states using affected versions face elevated risk of unauthorized access to patient data and potential system compromise. The severity of the flaws—particularly those enabling unauthenticated remote code execution with root privileges—could facilitate ransomware deployment or data exfiltration targeting healthcare infrastructure. This disclosure may prompt increased scrutiny from EU regulatory bodies, including ENISA and national supervisory authorities under NIS2, regarding software assurance practices among critical infrastructure vendors. Poland's proactive disclosure reinforces its positioning as a reliable cybersecurity partner within the EU and NATO, contributing to collective defense of the healthcare sector against both criminal and state-sponsored threats.

Forecast

If healthcare organizations fail to apply patches promptly, exploitation by ransomware operators targeting the health sector is likely, given the critical nature of the vulnerabilities and the sector's attractiveness to financially motivated actors. If CGM's patch deployment is delayed or incomplete across its European customer base, regulatory enforcement actions under NIS2 may follow, potentially including incident reporting requirements and supervisory measures. Should exploitation occur, it may prompt accelerated EU-level initiatives on software supply chain security and mandatory security testing for critical infrastructure vendors. Poland's CERT is likely to continue active vulnerability coordination, reinforcing its role in regional cybersecurity capacity building, particularly as the country assumes greater responsibility within EU cyber defense mechanisms.